Imagine receiving a prescription from your trusted pharmacy, only to discover it’s meant for someone else—and it ends up costing you your life. This is the tragic reality for a 92-year-old Texas man, Joseph Hamilton Broussard, whose story has sparked a wrongful death lawsuit that’s raising serious questions about pharmacy accountability. According to the lawsuit obtained by The Independent, Broussard’s longtime pharmacy, Mercury Drive Pharmacy in Houston, mistakenly gave him another patient’s medication, leading to a devastating 11-month decline in his health and, ultimately, his death.
But here’s where it gets even more alarming: Broussard took the medication as directed for 66 days, unaware that the pills were not meant for him. The drug in question? Pioglitazone, a diabetes medication sold under the brand name Actos. Broussard, who had multiple health issues including type 2 diabetes, high blood pressure, and congestive heart failure, was never prescribed this medication. And this is the part most people miss: Pioglitazone can promote fluid retention, which is particularly dangerous for individuals with congestive heart failure—a condition Broussard was already battling.
An expert opinion filed in the case by Dr. Jonathan David de Olano, a physician specializing in emergency medicine and toxicology, asserts that Broussard’s death was a direct result of receiving the wrong medication. The opinion highlights Mercury Drive Pharmacy’s alleged “negligence and breaches in the standard of care,” emphasizing that basic checks, such as verifying the patient’s name on the pill bottle, were overlooked. Is this a one-time mistake, or a symptom of a larger systemic issue in pharmacy practices?
Broussard’s health began to deteriorate rapidly after taking the medication. In October, he was hospitalized with shortness of breath and swollen ankles, symptoms linked to worsening congestive heart failure. Months later, after a bout of pneumonia, he was hospitalized again, this time for a full week. His condition continued to decline until his death on June 7, 2025. Of the 90 pioglitazone pills he was mistakenly given, 24 remained unused—a stark reminder of the tragedy that unfolded.
Dr. de Olano’s report is unequivocal: “Had Mr. Broussard not received this medication, it is more likely than not he would not have had an exacerbation of congestive heart failure or required hospitalization.” This case isn’t isolated. In recent years, similar medication errors have led to patient deaths, with some healthcare professionals even facing manslaughter charges. But does this mean pharmacies are doing enough to prevent such catastrophic mistakes?
Mercury Drive Pharmacy, a member of the Health Mart network owned by pharmaceutical giant McKesson, has yet to comment on the case. Broussard’s daughter, who filed the lawsuit, is seeking damages for her father’s physical and emotional suffering, medical expenses, and funeral costs, as well as punitive damages to deter future negligence. Her complaint accuses the pharmacy of acting with “conscious indifference” to her father’s well-being.
This heartbreaking story raises critical questions: How often do medication errors occur, and what measures are in place to prevent them? Are pharmacies prioritizing patient safety, or are they cutting corners in a rush to fill prescriptions? What do you think? Is this a tragic anomaly, or a sign of deeper issues in healthcare? Share your thoughts in the comments—this is a conversation that demands attention.
